MedTrace Logo

Monitoring the Effectiveness and Safety of COVID-19 Vaccines at National University of Colombia

NCT04887246 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4078

Last updated 2024-07-11

No results posted yet for this study

Summary

There are relevant questions that need to be answered about the effectiveness and safety of COVID-19 vaccines. The objective of this observational study is to follow up the clinical outcomes after vaccination in all the headquarters of the National University of Colombia. It is a project that is considered institutional importance and is part of the actions that the National University of Colombia has proposed to the national government to accompany the national vaccination program.

The proposed follow-up includes the sociodemographic, cultural, clinical and pharmacological characterization of the vaccinated population, including the report of adverse events occurring after the vaccination process, the behavior of the population after the administration of the vaccine, monitoring serological outcomes, identification of medication errors and therapeutic failure. Three stages are proposed in which the population affiliated to UNISALUD is gradually included, then the beneficiaries and later the student community and their families.

The scope of the attached protocol includes Stage I, which corresponds to teachers and administrative staff (active and retired) linked to UNISALUD.

Conditions

  • Covid19
  • SARS-CoV2 Infection

Interventions

BIOLOGICAL

COVID-19 vaccines

COVID-19 vaccines available at Colombia

Sponsors & Collaborators

  • Universidad Nacional de Colombia

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-15
Primary Completion
2022-04-15
Completion
2022-12-15

Countries

  • Colombia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04887246 on ClinicalTrials.gov